Icon Advisers Inc. Co. acquired a new stake in shares of Teleflex Inc. (NYSE:TFX) during the third quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 12,300 shares of the medical technology company’s stock, valued at approximately $2,067,000.

A number of other hedge funds also recently bought and sold shares of the stock. Tower Research Capital LLC TRC acquired a new position in shares of Teleflex during the second quarter worth about $118,000. Checchi Capital Advisers LLC increased its position in shares of Teleflex by 0.8% in the second quarter. Checchi Capital Advisers LLC now owns 837 shares of the medical technology company’s stock worth $148,000 after buying an additional 7 shares during the period. Welch & Forbes LLC acquired a new position in shares of Teleflex during the second quarter worth about $204,000. Broderick Brian C acquired a new position in shares of Teleflex during the second quarter worth about $207,000. Finally, Tocqueville Asset Management L.P. acquired a new position in shares of Teleflex during the third quarter worth about $211,000. 93.18% of the stock is owned by hedge funds and other institutional investors.

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Shares of Teleflex Inc. (NYSE:TFX) traded down 0.30% during midday trading on Tuesday, reaching $149.64. The company’s stock had a trading volume of 477,281 shares. The stock has a market capitalization of $6.59 billion, a PE ratio of 25.84 and a beta of 0.88. The stock’s 50 day moving average is $153.53 and its 200 day moving average is $169.30. Teleflex Inc. has a 12 month low of $125.28 and a 12 month high of $188.79.

Teleflex (NYSE:TFX) last issued its earnings results on Thursday, October 27th. The medical technology company reported $1.80 EPS for the quarter, beating the Zacks’ consensus estimate of $1.78 by $0.02. Teleflex had a return on equity of 15.66% and a net margin of 15.09%. The company earned $455.60 million during the quarter, compared to the consensus estimate of $461.80 million. During the same period in the previous year, the firm posted $1.60 earnings per share. Teleflex’s quarterly revenue was up 2.7% compared to the same quarter last year. On average, analysts forecast that Teleflex Inc. will post $7.30 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 15th. Stockholders of record on Tuesday, November 15th will be given a dividend of $0.34 per share. The ex-dividend date is Thursday, November 10th. This represents a $1.36 annualized dividend and a dividend yield of 0.91%. Teleflex’s dividend payout ratio is presently 23.49%.

COPYRIGHT VIOLATION WARNING: “12,300 Shares in Teleflex Inc. (TFX) Acquired by Icon Advisers Inc. Co.” was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this report on another publication, it was stolen and republished in violation of U.S. & international copyright & trademark laws. The original version of this report can be viewed at https://www.thecerbatgem.com/2016/11/29/12300-shares-in-teleflex-inc-tfx-acquired-by-icon-advisers-inc-co.html.

A number of equities analysts have recently issued reports on the company. Zacks Investment Research downgraded Teleflex from a “buy” rating to a “hold” rating in a research note on Wednesday, October 26th. Stephens downgraded Teleflex from an “overweight” rating to an “equal weight” rating in a research note on Friday, October 28th. Four equities research analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the stock. Teleflex presently has an average rating of “Buy” and a consensus target price of $171.33.

About Teleflex

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company markets and sells its products to hospitals and healthcare providers, across the world, through a combination of its direct sales force and distributors.

5 Day Chart for NYSE:TFX

Receive News & Stock Ratings for Teleflex Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Inc. and related stocks with our FREE daily email newsletter.